June 28, 2017
Israeli-start-up Medial EarlySign is successfully applying Machine Learning algorithms to ordinary blood test results and existing EMR data to identify pateitns at high risk of harboring life-threatening diseases. In May, the venture has been recognized as one of Gartner’s Cool Vendors in AI for Healthcare.
I asked Tomer Amit, VP of Corporate Marketing, about EarlySign’s work and achievements.
View the full Q&A here.